FDA Inspection 876606 — Geisinger Medical Center Blood Bank
The FDA completed an inspection of Geisinger Medical Center Blood Bank on April 30, 2014 in Danville, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 30, 2014
- Fiscal Year
- 2014
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Danville, PA (United States)